Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2013

Jun 7, 2013

33819_dirs_2013-06-07_c52478df-2b67-4796-8770-b892c6ac2039.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-05-24

Reporting Person: KOSHY GEORGE (chief accounting officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-24 Common Stock A 100000 $0.00 Acquired 149592 Direct
2013-06-01 Common Stock F 917 $1.76 Disposed 148675 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15344 Indirect

Footnotes

F1: Restricted stock units, with 1/4 vesting on May 24, 2014, 1/4 vesting on May 24, 2015, 1/4 vesting on May 24, 2016, and 1/4 vesting on May 24, 2017.

F2: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.

F3: Includes (1) 100,000 restricted stock units, with 50,000 of this vesting on each of May 24, 2014, May 24, 2015, May 24, 2016, and May 24, 2017; (2) 30,000 restricted stock units, with 10,000 of this vesting on each of January 27, 2014, January 27, 2015, and January 27, 2016; and (3) 2,500 restricted stock units vesting on June 1, 2014.

F4: Shares held in 401(k) account, in accordance with issuer's employer-match policies.